Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
6.64 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -328.066 | -239.476 | -186.479 | -87.006 | -61.879 |
Depreciation & Amortization
| 32.465 | 11.756 | 8.405 | 4.442 | 2.489 |
Deferred Income Tax
| -364.698 | 0 | 0.827 | 1.757 | 1.054 |
Stock Based Compensation
| 53.503 | 27.909 | 14.842 | 4.292 | 1.385 |
Change In Working Capital
| -50.257 | 104.921 | -0.306 | 30.834 | 0.408 |
Accounts Receivables
| -7.756 | -0.002 | 0.114 | -0.005 | -0.027 |
Inventory
| 0 | 0.002 | 7.835 | 4.357 | 0 |
Accounts Payables
| -0.987 | 1.767 | 1.745 | -0.185 | -0.34 |
Other Working Capital
| -41.514 | 103.154 | -10 | 26.667 | 0.775 |
Other Non Cash Items
| 369.273 | 11.366 | 4.097 | 0.282 | -0.499 |
Operating Cash Flow
| -287.78 | -83.524 | -158.614 | -45.399 | -57.042 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -12.552 | -37.359 | -39.798 | -6.735 | -3.91 |
Acquisitions Net
| 1.844 | 0 | 231.946 | -2.6 | 0 |
Purchases Of Investments
| 0.597 | 0 | -301.137 | 0 | 0 |
Sales Maturities Of Investments
| 0.48 | 230.608 | 69.191 | 0 | 0 |
Other Investing Activites
| -0.597 | 230.308 | -231.946 | 0.595 | 0 |
Investing Cash Flow
| -10.228 | 193.249 | -271.744 | -8.74 | -3.91 |
Financing Activities: | |||||
Debt Repayment
| -0.766 | -0.09 | -12.798 | -0.077 | -11.183 |
Common Stock Issued
| 140.899 | 143.711 | 462.901 | 239.812 | 119.705 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 140.133 | 10.724 | 8.437 | 6.4 | 11.888 |
Financing Cash Flow
| 140.133 | 154.345 | 458.54 | 246.135 | 120.41 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0.188 | -0.307 | 0 | 0 | 0 |
Net Change In Cash
| -156.396 | 263.763 | 28.182 | 191.996 | 59.458 |
Cash At End Of Period
| 394.796 | 559.112 | 295.349 | 267.167 | 75.171 |